VeriSIM Life

VeriSIM Life is a biotechnology company based in San Francisco, founded in 2017.

The company focuses on enhancing drug development through artificial intelligence and machine learning, aiming to reduce reliance on animal testing by utilizing computational biosimulation. Its mission is to increase human life expectancy and personalize patient treatment by improving research and development decisions before preclinical trials. The flagship product, BIOiSIMTM, is an AI-driven virtual drug development engine that models drug interactions across multiple species. This platform provides predictive insights into drug efficacy and safety, enabling researchers to forecast clinical trial outcomes and streamline the drug discovery process. VeriSIM Life serves a diverse B2B audience, including pharmaceutical companies, biotech firms, and academic institutions, helping them to de-risk R&D decisions and accelerate the development of new therapies. The company has received recognition for its innovative approach, including being named the "Predictive Analytics Solution of the Year" by BioTech Breakthrough in 2022.